×
0.000658327847267925 0.000658327847267925 -0.00921658986175119 0.000658327847267925 -0.0190915075707703 -0.0125082290980909 -0.0256747860434497 -0.000513495720869082
Stockreport

Aldeyra Therapeutics reports FY 2017 results [Seeking Alpha]

ALDEYRA THERAPEUTICS (ALDX)  More Company Research Source: Seeking Alpha
Last aldeyra therapeutics earnings: 8/8 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.aldeyra.com
PDF Aldeyra Therapeutics reports FY 2017 resultsAldeyra Therapeutics (ALDX)FY results: Revenues: $0; R&D Expense: $16.3M (+23.5%); SG&A: $6.2M (+12.7%); Operating Loss: ($22.5M) (-20.3%); Net Loss: ($22.3M) (-19.3%); Loss Per Share: ($1.40) (+15.2%); Quick Assets: $42.9M (+72.3%).Upcoming Events: Aldeyra enrolled its first patient into a Phase 2b clinical trial of reproxalap in dry eye disease in January, and expects to report results in the H2 2018.Aldeyra plans to begin a Phase 3 allergic conjunctivitis clinical trial of topical ocular reproxalap in the H1 2018. Results are expected in H2 2018, or early 2019.Based on an end of Phase 2 meeting with the FDA following favorable results from a Phase 2 trial in Sjögren-Larsson Syndrome, Aldeyra plans to initiate a global, double-blind, two-part Phase 3 clinical trial of topical dermatologic reproxalap in H1 2018. Results from part one are expected to be announced in 2019.Click to subscribe to real-time analytics on ALDXNow read:Protalix Shou [Read more]

IMPACT SNAPSHOT EVENT TIME: ALDX
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS